Biosimilars Saved European Countries €5.7bn Last Year, Says IQVIA Report
Medicines For Europe Urges Further Action To Translate Biosimilar Potential Into Reality
This year’s annual IQVIA report into European biosimilar competition has found savings in the market are at record highs, but Medicines for Europe says more action is needed to translate the potential of biosimilars into real-world changes.
